Recently, combination of CEA-CAR-NK-92 cells with the HDAC inhibitor sodium butyrate (NaB) led to CEA upregulation in CRC cells, increasing CEA-CAR-NK-92 cell-mediated killing in an in vivo model, leading to reduced tumor volumes (162). This evidence concerns the gene CEACAM5 and colorectal carcinoma.